Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells.
The new therapy, which has been demonstrated to make prostate cancer and breast cancer tumors more sensitive to chemotherapy, is currently close to entering clinical trials.
Researchers at UEA’s Norwich Medical School have established that it can be mass-produced, making it a practical treatment if ascertained as effective in human trials.
Using nanoparticles to send the drugs straight into a tumor is a growing area of cancer study. The technology created at UEA is the first of its kind to use nanoparticles to transport two drugs in combination to target cancer cells.
The drugs, already permitted for clinical use, are an anti-cancer drug known as docetaxel, and fingolimod, a multiple sclerosis drug that renders tumors more sensitive to chemotherapy.
Fingolimod cannot presently be used in cancer treatment as it also overpowers the immune system, leaving patients with seriously low levels of white blood cells.
While docetaxel is used to treat a number of cancers, mainly breast, stomach, prostate, head, and neck, and a few types of lung cancers, its poisonousness can also result in severe side effects for patients whose tumors are chemo-resistant.
Since the nanoparticles created by the UEA team can deliver the drugs straight to the tumor site, these risks are greatly lowered. Furthermore, the targeted approach means less of the drug is required to destroy the cancer cells.
Image Credit: University of East Anglia
News This Week
Frank Boehm: Publication of our new paper “Human Brain/Cloud Interface” in Frontiers in Neuroscience
Contributors: Nuno R. B. Martins, Amara Angelica, Yuriy Svidinenko, Frank J. Boehm, Ioan Opris, Mikhail A. Lebedev, Melanie Swan, Steven A. Garan, Jeffrey V. Rosenfeld, Tad Hogg, Robert A. Freitas Jr. et al Excerpt [...]
Abstract The progressive growth in nanotechnology approaches to diagnostics and therapeutics, especially for cancer, necessitates training physicians in nanoethics. This article explains why it is critical for medical education to include instruction in [...]
The rise of Candida auris embodies a serious and growing public health threat: drug-resistant germs. In May, an elderly man was admitted to the Brooklyn branch of Mount Sinai Hospital for abdominal surgery. A [...]
In a collaboration between the U.S. Department of Energy's Ames Laboratory and Northeastern University, scientists have developed a model for predicting the shape of metal nanocrystals or "islands" sandwiched between or below two-dimensional (2D) [...]
Should we be prepared to change the population composition of a species in order to wipe out a disease that is a terrible burden to mankind? During a well-attended working breakfast organised by the [...]
A new study led by Massachusetts General Hospital (MGH) investigators finds that radiation therapy may increase the uptake of therapeutic nanoparticles by glioblastomas, raising the possibility of using both growth-factor-targeted and immune-system-based therapies against [...]
Taking a cue from biological cells, researchers from MIT, Columbia University, and elsewhere have developed computationally simple robots that connect in large groups to move around, transport objects, and complete other tasks. This [...]
Nearly a third of physicians will be sued at least once in their careers — most commonly for an error in diagnosis. Medical errors are also the third-leading cause of death in the United [...]
Inventors and scientists have been continuously working towards reducing the size of technological components. Room-sized computers to laptops that are slimmer than a pane of glass? It’s done. Huge bulky telephones to smartphones that [...]
You have witnessed a variety of nano-devices that were designed for tasks including delivering medicines within the body. All of them used to move in a variety of ways. However, the latest nano-device is [...]
Netra Rajesh is an undergraduate Engineering Science student specializing in Biomedical Systems Engineering. She is currently on her Professional Experience Year (PEY) at the Massachusetts Institute of Technology where her research lies at the [...]